Please provide your email address to receive an email when new articles are posted on . Results of a study showed that antirituximab antibodies are common among patients with pemphigus who have been ...

Immunotherapy. 2012;4(7):735-745. In patients refractory to steroid therapy or those who cannot tolerate high steroid doses, other immunosuppressants are used. Recently, these alternative ...

Researchers compare a lymphoma-dose regimen of rituximab to a rheumatoid arthritis regimen for the treatment of pemphigus. Pemphigus, an autoimmune disease mediated by B cells and which causes painful ...

DSG3-CAART is designed to selectively target the cause of mucosal pemphigus vulgaris. The Food and Drug Administration (FDA) has granted Fast Track designation to DSG3-CAART (desmoglein 3 chimeric ...

Please provide your email address to receive an email when new articles are posted on . Rituximab is associated with higher protection against long-term cardiovascular and metabolic diseases, but ...

PARIS – September 9, 2021 – The Phase 3 PEGASUS trial evaluating rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet its primary or key secondary endpoints.

Patients with pemphigus reported lower risk of myocardial infarction and stroke, among other cardiovascular and metabolic outcomes, when treated with rituximab compared with the first-line ...

Fact.MR, a leading authority on market research brings original, in-depth, and insightful reports to investors On Pemphigus Vulgaris Treatment Market Sales & Demand. Report will highlight various ...

Discover top medications for 'treating Pemphigus'? This page compiles essential information on generic and brand-name drugs specifically used for Pemphigus treatment.Here, you can explore dosages, ...

Pemphigus foliaceus is an autoimmune disease that causes itchy blisters to form on your skin. It’s part of a family of rare skin conditions called pemphigus that produce blisters or sores on the skin, ...

MELBOURNE, May 15, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has unveiled a new report called "Pemphigus Vulgaris Treatment Market" which provides an in-depth exploration of growth ...

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus is ...